PR Newswire
Innovation is at the core of what we do
We are a molecular life science company dedicated to advancing human health through innovation. By designing and building breakthrough molecular platforms that are both accessible and best-in-class, One BioMed is providing biomedical researchers and clinicians with unprecedented access to cutting-edge tools.
PR Newswire
One BioMed launches the cartridge-based Xceler8™ Nucleic Acid Extraction Platform, the next generation in workflow simplification.
One BioMed
Healthcare Startup One BioMed closes $5M Series A
A*STAR
One BioMed & A*STAR launch $9M joint lab to make diagnostic kit for infectious diseases
A*STAR